Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Treatment Patterns and Outcomes from OASIS: A Prospective Observational Study of Long-Acting Injectables in Schizophrenia.
Journal: Neuropsychiatric disease and treatment
Published: April 22, 2025
Treatment Patterns and Healthcare Resource Utilization Following Initiation of Aripiprazole Lauroxil Using a 1-Day Initiation Regimen in Patients with Schizophrenia.
Journal: Advances in therapy
Published: February 27, 2025
Aripiprazole Lauroxil Every 2 Months or Paliperidone Palmitate Monthly for Acute Schizophrenia: A Post Hoc Analysis of PANSS Five-Factor Scores in the ALPINE Trial.
Journal: Neuropsychiatric disease and treatment
Published: December 05, 2024
Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia.
Journal: Neuropsychiatric disease and treatment
Published: October 16, 2024
Long-Acting Injectable Antipsychotic Initiation in Child and Adolescent Patients with Psychiatric Disorders.
Journal: Journal of child and adolescent psychopharmacology
Published: August 24, 2024
Initiating Aripiprazole Lauroxil: Post Hoc Analysis of Safety and Tolerability of 1-Day and 21-Day Regimens.
Journal: The Journal of clinical psychiatry
Published: August 15, 2024
A 16-Year-Old Male with Autism Spectrum Disorder, Psychosis, and Refusal to Accept Any Oral Medication: A Case Report and Use of Long-Acting Injectable Aripiprazole Lauroxil.
Journal: Journal of child and adolescent psychopharmacology
Published: July 24, 2024
Appropriate use of single-dose injectable aripiprazole lauroxil in the treatment of schizophrenia.
Journal: The mental health clinician
Published: May 15, 2024
Functioning and Cognition in Patients with Schizophrenia After Initiating Treatment with Aripiprazole Lauroxil: Secondary Outcomes and Post Hoc Analysis.
Journal: Innovations in clinical neuroscience
Published: March 18, 2024
Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized Controlled Trial.
Journal: The Journal of clinical psychiatry
Published: February 28, 2024
Evaluating the efficacy and safety of the currently available once-every-two months long-acting injectable formulations of aripiprazole for the treatment of schizophrenia or as a maintenance monotherapy for bipolar I disorder in adults.
Journal: Expert review of neurotherapeutics
Published: February 01, 2024
Last Updated: 10/31/2025